||The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (August 2015) (Learn how and when to remove this template message)|
NxStage Medical, Inc. is a publicly traded company (NASDAQ: NXTM) located in Lawrence, Massachusetts. It is a medical device company that develops, manufactures and markets systems for the treatment of end-stage renal disease, acute kidney failure and fluid overload.
In April 2002, IFS signed a contract with NxStage Medical, to provide IFS Applications(TM) business software to support the company's growing medical device business.
In 2005, NxStage Medical received expanded 510(k) clearance from the FDA for its System One portable daily hemodialysis device. On Nov 2, 2005, NxStage Medical, Inc. received the Nixon Peabody/Smith & Nephew Medical Device Innovation Award in the Start-Up category from the Massachusetts Medical Device Industry Council (MassMEDIC). It received an "honorable mention" in the Wall Street Journal's 2006 Technology Innovation Awards.On Nov 27, 2006, NxStage Medical, Inc. appointed Robert S. Brown as Chief Financial Officer effective immediately.
- "FS Will Implement Business Software for Medical Device Manufacturer NxStage Medical".
- "MassMEDIC Honors NxStage Medical with Innovation Award for Portable Home Hemodialysis System".
- "NxStage Medical, Inc. Appoints Robert S. Brown as Chief Financial Officer".
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|